India biotech corona vaccine will meet country’s needs soon

India biotech corona vaccine will meet country’s needs soon

India is going to make such a dose of biotech corona vaccine that the entire country’s needs can be met

India Biotech, the first corona vaccine maker in India, has announced an expansion in its production capacity. Releasing a press release on Tuesday (April 20), the company said it will now produce 700 million vaccine doses annually.

The company’s announcement comes at a time when India is facing a second wave of the coronavirus. More than 2.5 million cases are coming to light every day and more than a thousand people are dying. In the last 24 hours, 1761 people have died across the country.

India may need to be fulfilled

If India’s biotech produces 700 million vaccine doses as announced, it will greatly strengthen the covid vaccination program in the country. Significantly, the shortage of vaccine doses to prevent corona infection in the country has been clearly felt. The government also realizes it.

This has led to many important spreads in the recent past. These include decisions such as giving entry of foreign vaccines into India, speeding up the process of their approval.

There was significant news in this regard on Monday (April 19). India Today quoted sources as saying that the Central government has decided to provide a total of Rs 4500 crore to two of the country’s largest vaccine companies to prepare corona vaccine.

3000 crore to Serum Institute of India and Rs 1500 crore to Bharat Biotech. The very next day, today, Bharat Biotech issued a press release asking for a 700 million dose of vaccine.

Know about covaccine

Bharat Biotech has developed the vaccine in association with the Indian Council of Medical Research, the country’s largest medical research institute, ICMR. They also conducted joint trials in the final phase.

According to Bharat Biotech, 25,800 people were involved in the trial. Many of them were vaccinated, while some participants were given another drug plusibo to compare its effects.

Releasing the results of the trial, Bharat Biotech had reported that it was the largest human test ever conducted in the country. The company had claimed that the vaccine’s efficiency rate in the trial was found to be 81 percent after the second dose.

Let me tell you that this is the vaccine that PM Narendra Modi got while launching the second phase of corona vaccination in the country.

Price
Rs. 250 per dose in private hospitals and free in government hospitals. 🙂

Which vaccine in India?

At present, the use of three corona vaccines in India has been approved. Covichil, Covaccine, and Sputnik V. Covishield, and Covaccine are already part of the vaccination program and millions of people have been vaccinated so far. On the other hand, the Russian vaccine Sputnik V recently received emergency approval from the Drug Controller General of India (DCGI).

According to the Union Health Ministry, more than 109.6 million people have been given the first dose of the vaccine so far. On the other hand, the number of vaccine users taking the second dose is about 1.74 crore.

The update is based on data released until 7 a.m. on April 20.

CATEGORIES
Share This

AUTHORDeepa Chandravanshi

Deepa Chandravanshi is the founder of The Magadha Times & Chandravanshi. Deepa Chandravanshi is a writer, Social Activist & Political Commentator.

COMMENTS

Wordpress (0)
Disqus (0 )
error: Content is protected !! Subject to Legal Action By Chandravanshi Inc